ダウンロード数: 802
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
15_0587.pdf | 498.21 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 石神, 襄次 | ja |
dc.contributor.author | 原, 信二 | ja |
dc.contributor.author | 三田, 俊彦 | ja |
dc.contributor.author | 福田, 泰久 | ja |
dc.contributor.alternative | Ishigami, Joji | en |
dc.contributor.alternative | Hara, Shinji | en |
dc.contributor.alternative | Mita, Toshihiko | en |
dc.contributor.alternative | Fukuda, Yasuhisa | en |
dc.date.accessioned | 2010-06-02T06:18:37Z | - |
dc.date.available | 2010-06-02T06:18:37Z | - |
dc.date.issued | 1969-08 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/120029 | - |
dc.description.abstract | 1) Clinical results: Cephalexin (Lilly) was administered to 31 patients with urinary tract infection. Excellent result was seen in 21, fair 4, no effect 5, and one was lost from our clinic. Overall effectiveness was 83.3% in percentage. 2) Blood levels: The highest blood level of cephalexin after administration in dosage of 0.5 or 1.0g was observed in one hour. After that, the level continued to decraese for other three hours. 3) Urinary excretion: After oral administration of 1.0g cephalexin, more than 80 % of it was excreted in urine within 6 hours. 4) Antimicrobial potency: The potency of CEX against Staphylococcus, E. coli, Proteus and Klebsiella was 1/2 to 1/4 of CER. 5) Side effect: Only one of 31 patients complained of abdominal discomfort. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 京都大学医学部泌尿器科学教室 | ja |
dc.publisher.alternative | Department of Urology, Faculty of Medicine, Kyoto Univeersity | en |
dc.subject | Adolescent | en |
dc.subject | Adult | en |
dc.subject | Ampicillin/pharmacology | en |
dc.subject | Cephaloridine/pharmacology | en |
dc.subject | Cephalosporins/administration & dosage/blood/therapeutic use/urine | en |
dc.subject | Child | en |
dc.subject | Child, Preschool | en |
dc.subject | Cloxacillin/pharmacology | en |
dc.subject | Escherichia coli/drug effects | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Kanamycin/pharmacology | en |
dc.subject | Klebsiella/drug effects | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Proteus/drug effects | en |
dc.subject | Staphylococcus/drug effects | en |
dc.subject | Tetracycline/pharmacology | en |
dc.subject | Time Factors | en |
dc.subject | Urinary Tract Infections/drug therapy | en |
dc.subject.ndc | 494.9 | - |
dc.title | 泌尿器科領域におけるCephalexinの応用 | ja |
dc.title.alternative | Cephalexin for urinary tract infection | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 15 | - |
dc.identifier.issue | 8 | - |
dc.identifier.spage | 587 | - |
dc.identifier.epage | 595 | - |
dc.textversion | publisher | - |
dc.sortkey | 08 | - |
dc.address | 神戸大学医学部泌尿器科学教室 | ja |
dc.address.alternative | The Department of Urology, Kobe University School of Medicine | en |
dc.identifier.pmid | 4899651 | - |
dcterms.accessRights | open access | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.15 No.8 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。